Literature DB >> 21645873

The impact of atypical antipsychotic use on obstructive sleep apnea: a pilot study and literature review.

Afshin Shirani1, Sergio Paradiso, Mark Eric Dyken.   

Abstract

BACKGROUND: Limited evidence links atypical antipsychotics (AAs) use to sleep related respiratory dysfunction and greater severity of obstructive sleep apnea (OSA). The present paper reviews the published evidence and examines the impact of AA use on the presence and severity of OSA among subjects with clinically suspected OSA after adjusting for several confounds.
METHODS: Archives of the University of Iowa Sleep Laboratory from 2005 to 2009 were searched for patients using AAs at the time of diagnostic polysomnogram (PSG). PSG data of the 84 AA users with heterogeneous psychiatric disorders (of these 20 diagnosed only with depression) were subsequently compared to PSG data of two randomly selected, non-AA user groups from the same patient pool: (i) 200 subjects with a depressive disorder as the only psychiatric diagnosis, and (ii) 331 mentally healthy controls. PSG data were analyzed adjusting for known demographic, medical, and psychiatric risk factors for OSA.
RESULTS: Prevalence and severity of OSA did not differ significantly across three groups. Sex, age, body mass index (BMI), and neck circumference (NC) independently predicted OSA. Odds ratio for OSA in the subset of AA users carrying the diagnosis of depression (n=20) compared with subjects without mental illness was 4.53 (p<.05). By contrast, AA users without depression or those with multiple psychiatric diagnoses including depression did not show a statistically significantly elevated OSA risk.
CONCLUSIONS: AA use in subjects with depression appears to increase the risk of OSA after controlling for known predisposing factors.
Copyright © 2011 Elsevier B.V. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645873      PMCID: PMC3789524          DOI: 10.1016/j.sleep.2010.12.013

Source DB:  PubMed          Journal:  Sleep Med        ISSN: 1389-9457            Impact factor:   3.492


  76 in total

1.  5HT2A and 5HT2C receptor polymorphisms and predicting clinical response to olanzapine in schizophrenia.

Authors:  Vicki L Ellingrod; Paul J Perry; Brian C Lund; Kristy Bever-Stille; Frank Fleming; Timothy L Holman; Del Miller
Journal:  J Clin Psychopharmacol       Date:  2002-12       Impact factor: 3.153

Review 2.  Abnormalities in glucose regulation associated with mental illness and treatment.

Authors:  Dan W Haupt; John W Newcomer
Journal:  J Psychosom Res       Date:  2002-10       Impact factor: 3.006

3.  The effects of breathing-related sleep disorders on mood disturbances in the general population.

Authors:  Maurice M Ohayon
Journal:  J Clin Psychiatry       Date:  2003-10       Impact factor: 4.384

Review 4.  Serotonin agonists and antagonists in obstructive sleep apnea: therapeutic potential.

Authors:  Sigrid C Veasey
Journal:  Am J Respir Med       Date:  2003

Review 5.  Atypical antipsychotics and glucose dysregulation: a systematic review.

Authors:  Hua Jin; Jonathan M Meyer; Dilip V Jeste
Journal:  Schizophr Res       Date:  2004-12-01       Impact factor: 4.939

6.  Protriptyline in obstructive sleep apnea: a double-blind trial.

Authors:  L G Brownell; P West; P Sweatman; J C Acres; M H Kryger
Journal:  N Engl J Med       Date:  1982-10-21       Impact factor: 91.245

7.  A retrospective cohort study of diabetes mellitus and antipsychotic treatment in the United States.

Authors:  John B Buse; Patrizia Cavazzoni; Kenneth Hornbuckle; David Hutchins; Alan Breier; Lois Jovanovic
Journal:  J Clin Epidemiol       Date:  2003-02       Impact factor: 6.437

8.  Aging and sleep apnea: action of benzodiazepine, acetazolamide, alcohol, and sleep deprivation in a healthy elderly group.

Authors:  C Guilleminault; R Silvestri; S Mondini; S Coburn
Journal:  J Gerontol       Date:  1984-11

Review 9.  Sleep in schizophrenia patients and the effects of antipsychotic drugs.

Authors:  Jaime M Monti; Daniel Monti
Journal:  Sleep Med Rev       Date:  2004-04       Impact factor: 11.609

Review 10.  Benzodiazepines, breathing, and sleep.

Authors:  C Guilleminault
Journal:  Am J Med       Date:  1990-03-02       Impact factor: 4.965

View more
  9 in total

1.  A weight-independent association between atypical antipsychotic medications and obstructive sleep apnea.

Authors:  Habibolah Khazaie; Amir Sharafkhaneh; Sepideh Khazaie; Mohammad Rasoul Ghadami
Journal:  Sleep Breath       Date:  2017-07-13       Impact factor: 2.816

2.  [Prevalence of sleep-related breathing disorders of inpatients with psychiatric disorders].

Authors:  M Behr; J Acker; S Cohrs; M Deuschle; H Danker-Hopfe; R Göder; C Norra; K Richter; D Riemann; C Schilling; H-G Weeß; T C Wetter; L M Wollenburg; T Pollmächer
Journal:  Nervenarzt       Date:  2018-07       Impact factor: 1.214

3.  [Sleep medicine in psychiatry and psychotherapy].

Authors:  Marcel Zeising; Christian Thiedemann; Thomas Pollmächer
Journal:  Nervenarzt       Date:  2022-02-24       Impact factor: 1.214

4.  Risk of obstructive sleep apnoea syndrome among in-patients at a neuropsychiatric hospital in Nigeria: a short report.

Authors:  Bawo O James; Chinwe F Inogbo; Atim O Archibong
Journal:  Afr Health Sci       Date:  2015-09       Impact factor: 0.927

Review 5.  Obstructive sleep apnea: management considerations in psychiatric patients.

Authors:  Taryn Heck; Monica Zolezzi
Journal:  Neuropsychiatr Dis Treat       Date:  2015-10-15       Impact factor: 2.570

6.  Risk Factors for Obstructive Sleep Apnea Are Prevalent in People with Psychosis and Correlate with Impaired Social Functioning and Poor Physical Health.

Authors:  Dennis Liu; Hannah Myles; Debra L Foley; Gerald F Watts; Vera A Morgan; David Castle; Anna Waterreus; Andrew Mackinnon; Cherrie Ann Galletly
Journal:  Front Psychiatry       Date:  2016-08-31       Impact factor: 4.157

7.  Is obstructive sleep apnea the missing link between metabolic syndrome and second-generation antipsychotics: Preliminary study.

Authors:  Rupali Rohatgi; Ravi Gupta; Rajat Ray; Vinita Kalra
Journal:  Indian J Psychiatry       Date:  2018 Oct-Dec       Impact factor: 1.759

8.  Causes of death in Prader-Willi syndrome: lessons from 11 years' experience of a national reference center.

Authors:  Dibia Liz Pacoricona Alfaro; Perrine Lemoine; Virginie Ehlinger; Catherine Molinas; Gwénaëlle Diene; Marion Valette; Graziella Pinto; Muriel Coupaye; Christine Poitou-Bernert; Denise Thuilleaux; Catherine Arnaud; Maithé Tauber
Journal:  Orphanet J Rare Dis       Date:  2019-11-04       Impact factor: 4.123

9.  Benefit of continuous positive airway pressure on work quality in patients with severe obstructive sleep apnea.

Authors:  Elsa Botokeky; N Freymond; F Gormand; P Le Cam; G Chatte; J Kuntz; M N Liegeon; M Gaillot-Drevon; A Massardier-Pilonchery; A Fiquemont; E Fort; M Marcu; T Petitjean; B Charbotel
Journal:  Sleep Breath       Date:  2019-01-26       Impact factor: 2.655

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.